Selenium induced anticonvulsant effect: A potential role of prostaglandin E1 receptor activation linked mechanism

Journal of Trace Elements in Medicine and Biology

Volumn 27, Issue 1, 2013, Pages 31-39

  Rehni, Ashish K ^a   Singh, Thakur Gurjeet ^a  

^a CHITKARA UNIVERSITY   (India)

Author keywords

Celecoxib; Misoprostol; Prostaglandin E1 receptors; Seleno dl methionine; Sodium selenite

Indexed keywords

ANTICONVULSIVE AGENT; CELECOXIB; METHIONINE; MISOPROSTOL; PENTETRAZOLE; PROSTAGLANDIN E1; PROSTAGLANDIN RECEPTOR; REACTIVE OXYGEN METABOLITE; SELENIUM; SODIUM SELENITE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG POTENTIATION; EPILEPSY; EXPERIMENTAL ANIMAL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MISOPROSTOL; PENTYLENETETRAZOLE; RECEPTORS, PROSTAGLANDIN E; SEIZURES; SELENOMETHIONINE; SODIUM SELENITE; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; MUS;

EID: 84872420374     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.05.001     Document Type: Article

References (36)

1. Kutluhan S., Naziroglu M., Celik O., Ylmaz M. Effects if selenium and topiramate on lipid peroxidation anti oxidant vitamin levels in blood of pentylentetrazol-induced epileptic rat. Biol Trace Elem Res 2009, 129:181-189.
2. Ozdemir E., Cetinkaya S., Eran S., Kucukosman S., Ersan E.E. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:62-65.
3. Atif F., Yousuf S., Aggarwal S.K. Restraint stress-induced oxidative damage and its amelioration with selenium. Eur J Pharmacol 2008, 600:59-63.
4. Moghadaszadesh B., Beggs A.H. Selenoproteins and their impact on human health through diverse physiological pathways. Physiology 2006, 21:307-315.
5. Rhee S.G., Chae H.Z., Kim K. Peroxiredoxns: a historical overview and speculative preview in cell signaling. Free Radic Biol Med 2005, 38:1543-1552.
6. Prohaska J.R., Ganther H.E. Selenium and glutathione peroxidase in developing rat brain. J Neurochem 1976, 27:1379-1387.
7. Stadtman T.C. Selenocysteine. Annu Rev Biochem 1996, 65:83-100.
8. Weber G.F., Maertens P., Meng X.Z., Pippenger C.E. Glutathione peroxidase deficiency and childhood seizures. Lancet 1991, 337:1443-1444.
9. Ramaekers V.T., Calomme M., Vanden Berghe D., Makropoulos W. Selenium deficiency triggering intractable seizures. Neuropediatrics 1994, 25:217-223.
10. Rubin J.J., Willmore L.J. Prevention of iron-induced epileptiform discharges in rats by treatment with antiperoxidants. Exp Neurol 1980, 67:472-480.
11. Willmore L.J., Rubin J.J. Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies. Neurology 1981, 31:63-69.
12. Kim H.C., Jhoo W.K., Choi D.Y., Im D.H., Shin E.J., Suh J.H., et al. Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res 1999, 851:76-86.
13. Kim H., Jhoo W., Shin E., Bing G. Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model. Brain Res 2000, 862:247-252.
14. Al Deeb S., Al Moutaery K., Bruyn G.W., Tariq M. Neuroprotective effect of selenium on iminodipropionitrile-induced toxicity. J Psychiatry Neurosci 1995, 20:189-192.
15. Imam S.Z., Newport G.D., Islam F., Slikker W., Ali S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res 1999, 818:575-578.
16. Zafar K.S., Siddiqui A., Sayeed I., Ahmad M., Salim S., Islam F. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Neurochem 2003, 84:438-446.
17. Savaskan N.E., Brauer A.U., Kuhbacher M., Eyupoglu I.Y., Kyriakopoulos A., Ninnemann O., et al. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. FASEB J 2003, 17:112-114.
18. Czerniecki B.J., Witz G. Arachidonic acid potentiates superoxide anion radical production by murine peritoneal macrophages stimulated with tumor promoters. Carcinogenesis 1989, 10(10):1769-1775.
19. Pepicelli O., Fedele E., Bonanno G., Raiteri M., Ajmone-Cat M.A., Greco A., et al. In vivo activation of N-methyl-d-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem 2002, 81(5):1028-1034.
20. Santos F., Teixeira L., Lúcio M., Ferreira H., Gaspar D., Lima J.L., et al. Interactions of sulindac and its metabolites with phospholipid membranes: an explanation for the peroxidation protective effect of the bioactive metabolite. Free Radic Res 2008, 42(7):639-650.
21. Sayyah M., Javad-Pour M., Ghazi-Khansari M. The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins. Neuroscience 2003, 122(4):1073-1080.
22. Zhang W., Wang Y., Chen C.W., Xing K., Vivekanandan S., Lou M.F. The positive feedback role of arachidonic acid in the platelet-derived growth factor-induced signaling in lens epithelial cells. Mol Vis 2006, 12:821-831.
23. Graham D.Y., Agrawal N.M., Roth S.H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988, 2:1277-1280.
24. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999, 96:272-277.
25. Bastian J.W., Krause W.E., Ridlon S.A., Ercoli N. CNS drug specificity as determined by the mouse intravenous pentylenetetrazole technique. J Pharmacol Exp Ther 1995, 127:75-80.
26. Rehni A.K., Singh I., Kumar M. Tramadol induced seizurogenic effect: a possible role of opioid dependent-GABA inhibitory pathway. Basic Clin Pharmacol Toxicol 2008, 103(3):262-266.
27. Rehni A.K., Singh T.G., Singh N., Arora S. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism. Naunyn Schmiedeberg's Arch Pharmacol 2010, 381(1):11-19.
28. Tallarida R.J., Porreca F., Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 1989, 45:947-961.
29. Santos I.M., Tomé Ada R., Saldanha G.B., Ferreira P.M., Militão G.C., Freitas R.M. Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid. Oxid Med Cell Longev 2009, 2(4):214-221.
30. Tomé Ada R., Ferreira P.M., Freitas R.M. Inhibitory action of antioxidants (ascorbic acid or alpha-tocopherol) on seizures and brain damage induced by pilocarpine in rats. Arq Neuropsiquiatr 2010, 68(3):355-361.
31. Mehla J., Reeta K.H., Gupta P., Gupta Y.K. Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life Sci 2010, 87(19-22):596-603.
32. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 2006, 12(2):225-229.
33. Santamaría A., Salvatierra-Sánchez R., Vázquez-Román B., Santiago-López D., Villeda-Hernández J., Galván-Arzate S., et al. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J Neurochem 2003, 86(2):479-488.
34. Willmore L.J. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 1990, 31(3):S67-S73.
35. Jung K.H., Chu K., Lee S.T., Kim J., Sinn D.I., Kim J.M., et al. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol Dis 2006, 23(2):237-246.
36. Li Y.B., Han J.Y., Jiang W., Wang J. Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells. Mol Biol Rep 2011, 38(4):2301-2306.